Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERENUMAB-AOOE Cause Treatment failure? 507 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 507 reports of Treatment failure have been filed in association with ERENUMAB-AOOE. This represents 1.0% of all adverse event reports for ERENUMAB-AOOE.

507
Reports of Treatment failure with ERENUMAB-AOOE
1.0%
of all ERENUMAB-AOOE reports
398
Deaths
338
Hospitalizations

How Dangerous Is Treatment failure From ERENUMAB-AOOE?

Of the 507 reports, 398 (78.5%) resulted in death, 338 (66.7%) required hospitalization, and 339 (66.9%) were considered life-threatening.

Is Treatment failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERENUMAB-AOOE. However, 507 reports have been filed with the FAERS database.

What Other Side Effects Does ERENUMAB-AOOE Cause?

Accidental exposure to product (9,923) Device difficult to use (9,530) Wrong technique in product usage process (9,359) Drug dose omission by device (6,340) Migraine (4,290) Drug ineffective (3,813) Constipation (3,104) Product storage error (2,958) Headache (2,787) Injection site pain (2,715)

What Other Drugs Cause Treatment failure?

METHOTREXATE (14,672) ETANERCEPT (11,893) ADALIMUMAB (9,990) ABATACEPT (9,301) RITUXIMAB (9,217) TOCILIZUMAB (9,097) HYDROXYCHLOROQUINE (8,786) LEFLUNOMIDE (8,686) INFLIXIMAB (8,535) SULFASALAZINE (7,423)

Which ERENUMAB-AOOE Alternatives Have Lower Treatment failure Risk?

ERENUMAB-AOOE vs ERENUMAB\ERENUMAB-AOOE ERENUMAB-AOOE vs ERGOCALCIFEROL ERENUMAB-AOOE vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL ERENUMAB-AOOE vs ERIBULIN ERENUMAB-AOOE vs ERLOTINIB

Related Pages

ERENUMAB-AOOE Full Profile All Treatment failure Reports All Drugs Causing Treatment failure ERENUMAB-AOOE Demographics